Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data
Authors' conclusion
The results indicate in the real-world environment that CGM is worn consistently over many years for both patients with T1D and T2D within the Veterans Affairs Healthcare System and is similar across major race/ethnic groups and age-groups.
Study context
- Population
- Patients with T1D and T2D using Dexcom continuous glucose monitoring (CGM) in the national Veterans Affairs Healthcare System, 2015 to 2020
- Outcome
- Patterns of CGM use
- Follow-up
- Nearly 3 years
Methodological detailsnational cohort, CGM device data linked with electronic health records (EHR)
- National cohort
- CGM device data linked with EHR
Main finding
As reported in the abstract
- Time from pharmacy release of CGM to initiation of uploading CGM data averaged 3 weeks, with wide variation among individuals; delay decreased markedly over later years
- Average daily wear time of CGM exceeded 22 h
- Patterns of CGM use generally consistent across age, race/ethnicity groups and diabetes type
Observational data: associations, not effects.
Further findings
Concordance of EHR-based and CGM device data
- Strong concordance between EHR-based estimates of CGM use and Dexcom CGM wear time, and between estimates of glucose control from both sources
Original publication
Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data. Diabetes Technol Ther. Published 11 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →